The wild-derived inbred mouse strain SPRET/Ei is resistant to LPS and defective in IFN-beta production.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Park, Jin Mo
van Roy, Frans
MetadataShow full item record
AbstractAlthough activation of Toll-like receptor 4 (TLR4)-positive cells is essential for eliminating Gram-negative bacteria, overactivation of these cells by the TLR4 ligand LPS initiates a systemic inflammatory reaction and shock. Here we demonstrate that SPRET/Ei mice, derived from Mus spretus, exhibit a dominant resistance against LPS-induced lethality. This resistance is mediated by bone marrow-derived cells. Macrophages from these mice exhibit normal signaling and gene expression responses that depend on the myeloid differentiation factor 88 adaptor protein, but they are impaired in IFN-beta production. The defect appears to be specific for IFN-beta, although the SPRET/Ei IFN-beta promoter is normal. In vivo IFN-beta induction by LPS or influenza virus is very low in SPRET/Ei mice, but IFN-beta-treatment restores the sensitivity to LPS, and IFN type 1 receptor-deficient mice are also resistant to LPS. Because of the defective induction of IFN-beta, these mice are completely resistant to Listeria monocytogenes and highly sensitive to Leishmania major infection. Stimulation of SPRET/Ei macrophages leads to rapid down-regulation of IFN type 1 receptor mRNA expression, which is reflected in poor induction of IFN-beta-dependent genes. This finding indicates that the resistance of SPRET/Ei mice to LPS is due to disruption of a positive-feedback loop that amplifies IFN-beta production. In contrast to TLR4-deficient mice, SPRET/Ei mice resist both LPS and sepsis induced with Klebsiella pneumoniae.
CitationThe wild-derived inbred mouse strain SPRET/Ei is resistant to LPS and defective in IFN-beta production. 2006, 103 (7):2292-7 Proc. Natl. Acad. Sci. U.S.A.
AffiliationDepartment for Molecular Biomedical Research, Flanders Interuniversity Institute for Biotechnology and Ghent University, Technologiepark 927, B-9052 Ghent, Belgium.
- Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN-beta.
- Authors: Hirotani T, Yamamoto M, Kumagai Y, Uematsu S, Kawase I, Takeuchi O, Akira S
- Issue date: 2005 Mar 11
- Contribution of interferon-beta to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide.
- Authors: Thomas KE, Galligan CL, Newman RD, Fish EN, Vogel SN
- Issue date: 2006 Oct 13
- Endogenous IFN-alpha beta suppresses colony-stimulating factor (CSF)-1-stimulated macrophage DNA synthesis and mediates inhibitory effects of lipopolysaccharide and TNF-alpha.
- Authors: Hamilton JA, Whitty GA, Kola I, Hertzog PJ
- Issue date: 1996 Apr 1
- Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse.
- Authors: Mohammad MK, Morran M, Slotterbeck B, Leaman DW, Sun Y, Grafenstein Hv, Hong SC, McInerney MF
- Issue date: 2006 Jul
- Antagonism between MyD88- and TRIF-dependent signals in B7RP-1 up-regulation.
- Authors: Zhou Z, Hoebe K, Du X, Jiang Z, Shamel L, Beutler B
- Issue date: 2005 Jun